TITLE

Misuse of Inhaled Bronchodilator Agents

AUTHOR(S)
Saunders, K. B.
PUB. DATE
April 1965
SOURCE
British Medical Journal;4/17/1965, Vol. 1 Issue 5441, p1037
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64058445

 

Related Articles

  • Chronic Obstructive Pulmonary Disease: Emerging Trends in Pharmacotherapy. Restrepo, Ruben D.; Hanania, Nicola A. // Current Medical Literature: Respiratory Medicine;2009, Vol. 23 Issue 2, p29 

    The article reviews emerging therapies for the treatment of stable chronic obstructive pulmonary disease (COPD). The two categories of inhaled agents for the management of stable COPD are bronchodilators and corticosteroids. It explains in detail the use of novel biological targets like novel...

  • Bronchodilator Combination Therapy for the Treatment of Chronic Obstructive Pulmonary Disease. Sethi, Sanjay // Current Clinical Pharmacology;Feb2011, Vol. 6 Issue 1, p48 

    Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality, and its prevalence is rising worldwide. Bronchodilators remain the cornerstone of COPD treatment, especially inhaled �2-adrenergic receptor agonists and inhaled anticholinergics. Long-acting...

  • An anesthetic in use with bronchodilator inhaler: A fact less known. Kummar, Prashant; Korula, Grace; Ninan, Sarah; Karthikeyan, Chandrasekaran // Annals of Cardiac Anaesthesia;Jan2010, Vol. 13 Issue 1, p77 

    A letter to the editor is presented about the use of anesthetics with bronchodilator inhaler.

  • albuterol.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p71 

    A definition of the term "albuterol," which refers to a bronchodilator administered by inhalation or tablet, is presented.

  • Aerosol Use in the Pulmonary Function Lab... includes discussion by Berlinski, Ruppel, Suggett. Ruppel, Gregg L. // Respiratory Care;Jun2015, Vol. 60 Issue 6, p931 

    Aerosolized medications are frequently used in the pulmonary function laboratory. The 2 most common implementations are bronchodilators and bronchial challenge agents. Bronchodilator administration is not well standardized, largely because of the various methods of delivery available for...

  • Diagnosis and management of inhalation injury: an updated review. Walker, Patrick F.; Buehner, Michelle F.; Wood, Leslie A.; Boyer, Nathan L.; Driscoll, Ian R.; Lundy, Jonathan B.; Cancio, Leopoldo C.; Chung, Kevin K. // Critical Care;10/28/2015, Vol. 19, p1 

    In this article we review recent advances made in the pathophysiology, diagnosis, and treatment of inhalation injury. Historically, the diagnosis of inhalation injury has relied on nonspecific clinical exam findings and bronchoscopic evidence. The development of a grading system and the use of...

  • Cystic Fibrosis: A Review of Pathophysiology and Current Treatment Recommendations. Peters, Stacy // South Dakota Medicine;Apr2014, Vol. 67 Issue 4, p148 

    The article discusses the pathophysiology and treatment recommendations for cystic fibrosis (CF). It details the symptoms of the autosomal life-limiting disease, its diagnosis and epidemiology, and genetics. It explores the common therapies and multiple modalities to treat the viscous mucus,...

  • How to inhale.  // Consumer Reports on Health;Jan94, Vol. 6 Issue 1, p10 

    Discusses the proper use of inhalers for asthma control. Effect of inhalers misuse; Recommendation on the proper use of inhalers.

  • Optimizing bronchodilation in COPD: double bronchodilator therapy. Beeh, Kai M.; Beier, Jutta // Hot Topics in Respiratory Medicine;2012, Vol. 7 Issue 21, p13 

    Bronchodilators are the cornerstone of symptomatic treatment for chronic obstructive pulmonary disease (COPD). They are recommended on a regular basis to prevent or reduce symptoms and exacerbations, with a preference for long-acting therapy rather than short-acting drugs. There are 2 classes of...

  • Optimizing bronchodilatation in COPD: double bronchodilator therapy. Beeh, Kai M.; Beier, Jutta // Hot Topics in Respiratory Medicine;2014, Vol. 9 Issue 26, p13 

    Bronchodilators are the cornerstone of symptomatic treatment for COPD. They are recommended on a regular basis to prevent or reduce symptoms and exacerbations, with a preference for long-acting over short-acting drugs. There are two classes of bronchodilators with distinct modes of action,...

Share

Read the Article

Other Topics